Immune checkpoint blockade (ICB) therapies can be very effective against some cancers by helping the immune system recognize ...

An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, ...

A phase 1 trial of α-lactalbumin vaccine for the treatment of patients with triple-negative breast cancer demonstrated safety ...

A breast cancer vaccine could be closer to reality ... "Our hope is that future studies will demonstrate that the antigen-specific T cell responses we observed translate to the prevention of ...

Argonne has received up to $21 million from ARPA-H to use AI and supercomputing in two projects: one targeting hard-to-treat ...

Dendritic cells are poised to revolutionize oncology. This type of immune therapy shows effectiveness even in late-stage ...

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

An experimental vaccine teaching patients’ immune systems to identify and attack cancer cells could help women diagnosed with ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an ...

Results showed that 14 out of the 18 patients with triple-negative breast cancer developed an immune response to the vaccine. "We are excited about the promise of these neo-antigen vaccines ...

Results showed that 14 out of the 18 patients with triple-negative breast cancer developed an immune response to the vaccine. “We are excited about the promise of these neo-antigen vaccines ...